(Q39766811)

14 September 2017

title

Informed consent in the context of pharmacogenomic research: ethical considerations (English)

1 reference

14 September 2017

0 references

0 references

0 references

1 reference

H C Howard

1

1 reference

14 September 2017

Y Joly

2

1 reference

14 September 2017

D Avard

3

1 reference

14 September 2017

N Laplante

4

1 reference

14 September 2017

M Phillips

5

1 reference

14 September 2017

J C Tardif

6

1 reference

14 September 2017

language of work or name

1 reference

29 March 2011

1 reference

The Pharmacogenomics Journal

14 September 2017

published in

1 reference

14 September 2017

volume

11

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

155-161

1 reference

Implications of pharmacogenomics for drug development and clinical practice

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Pharmacogenomics: implications and considerations for pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Should donors be allowed to give broad consent to future biobank research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Should pharmacogenomic studies be required for new drug approval?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

The uneasy ethical and legal underpinnings of large-scale genomic biobanks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Human genetic research: emerging trends in ethics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Development of a large-scale de-identified DNA biobank to enable personalized medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Pharmacogenomic data sample collection and storage: ethical issues and policy approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Ancillary risk information and pharmacogenetic tests: social and policy implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

The charitable trust as a model for genomic biobanks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Genetics. Genomic research and human subject privacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Pharmacogenetics: the bioethical problem of DNA investment banking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Looking for race in all the wrong places: analyzing the lack of productivity in the ongoing debate about race and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

Genetic research and culturally specific risks: one size does not fit all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

The complex relationship of genetics, groups, and health: what it means for public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.11

21 January 2018

Identifiers

DOI

10.1038/TPJ.2011.11

1 reference

Dimensions Publication ID

14 September 2017

1006294841

0 references

1 reference